Intuitive Surgical acquires Schölly Fiberoptic’s robotic endoscope business
Intuitive is acquiring the robotic endoscope portion of Schölly Fiberoptic’s business. This acquisition will integrate Schölly’s robotic endoscope manufacturing line, and two Schölly sites into Intuitive operations: the robotic-related manufacturing line from Denzlingen,
“Schölly has been an important and valued vendor for Intuitive since the very early days of the company,” said
“Leading visualization has been a core pillar of our company and we expect it to continue to be important going forward,” said Miller. “It makes sense to bring the teams together for both organizations.”
Schölly Fiberoptic is a leading player in the field of visualization systems for minimally invasive diagnostic and surgical applications, headquartered in Germany—and one of Intuitive’s strategic suppliers. The companies have worked together for more than 20 years, designing and manufacturing several generations of imaging systems for Intuitive’s da
Schölly Fiberoptic will continue to be a valuable vendor for Intuitive; other businesses in the region should continue to benefit from Intuitive’s expansion.
“Application-specific and advanced image quality is our passion and the key for successful and safe minimally invasive surgery,” said Prof. Dr.
In addition to bringing important aspects of da Vinci’s visualization system under Intuitive, the acquisition will help strengthen Intuitive’s supply chain, and increase its manufacturing capacity for imaging products.
Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings, and develops, manufactures, and markets the da Vinci® surgical system and the Ion™ endoluminal system.
For more information, please visit the Company’s website at www.intuitive.com.
From endoscopes, camera systems, and light modules, all the way to complex visualization systems, the company offers a wide range of products and services. Schölly was and is the driving force behind the transition from 2D to 3D visualization systems and in the miniaturization of endoscopes.
The company was founded in 1973 and has about 900 employees worldwide. Its six sales and service branches are, along with the corporate headquarters, responsible for the support of the globally active customers and the acquisition of new projects. In 2018 Schölly had a turnover of
More information at www.schoelly.de.
Global Public Affairs
Forward Looking Statements
This press release contains forward-looking statements, including statements regarding the Company’s acquisition of Schölly Fiberoptic’s robotic endoscope business. These forward-looking statements are necessarily estimates reflecting the best judgment of the Company’s management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: the risk that the acquisition may not close, or the Company cannot successfully manufacture robotic endoscopes after the acquisition, the risks associated with integrating a new business that involves complex manufacturing and repair operations across different geographic locations, the timing and success of product development and market acceptance of developed products, including, but not limited to, the Ion endoluminal system, the da Vinci SP surgical system, and 3rd generation stapling platform; the impact of global and regional economic and credit market conditions on healthcare spending; competition in the medical device industry and in the specific markets of surgery in which the Company operates; risks associated with our operations outside of the
Source: Intuitive Surgical, Inc.